Stay updated on Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAccess to the study record now leads to a 403 Forbidden error page, replacing the previous study details. The new page includes a Home button and the standard site footer, indicating an access restriction rather than an update to the study content.SummaryDifference0.5%

- Check27 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study record details with an access-denied message.SummaryDifference18%

- Check48 days agoChange DetectedThe study page now shows a new revision label (v3.6.6) replacing the previous version. This indicates a small metadata update to the page without changing substantive content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now includes a funding source note indicating an NIH grant/contract from 2018, clarifying the source of support for the trial. This addition provides funding transparency without changing how the study is conducted or presented to participants.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5 on the page, indicating a maintenance release. No substantive content changes are present.SummaryDifference0.0%

Stay in the know with updates to Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Upadacitinib Pharmacokinetics in Atopic Dermatitis Clinical Trial page.